Profile data is unavailable for this security.
About the company
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
- Revenue in EUR (TTM)493.25m
- Net income in EUR35.83m
- Incorporated1967
- Employees2.81k
- LocationBoiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
- Phone+33 478456100
- Fax+33 478456291
- Websitehttps://www.boiron.fr/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beijing Luzhu Biotechnology Co Ltd | 0.00 | -31.73m | 534.71m | 133.00 | -- | 4.12 | -- | -- | -1.34 | -1.34 | 0.00 | 5.42 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
ZhuZhou QianJin Pharmaceutical Co., Ltd | 488.53m | 41.06m | 536.31m | 5.34k | 13.17 | 1.71 | -- | 1.10 | 0.7546 | 0.7546 | 8.94 | 5.82 | 0.8283 | 3.58 | 9.76 | 719,592.90 | 8.61 | 8.99 | 16.26 | 16.21 | 45.46 | 44.59 | 10.40 | 10.03 | 1.95 | -- | 0.1297 | 68.27 | -5.66 | 2.68 | 5.53 | 4.64 | -1.06 | -2.64 |
Jiangsu Jibeier Pharmaceutical Co Ltd | 113.23m | 29.73m | 542.70m | 1.45k | 17.44 | 2.09 | -- | 4.79 | 1.24 | 1.24 | 4.74 | 10.37 | 0.426 | 3.13 | 5.33 | 615,794.80 | 11.17 | 9.77 | 12.06 | 10.66 | 87.87 | 88.44 | 26.22 | 23.29 | 6.76 | -- | 0.005 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
Aarti Drugs Ltd | 280.07m | 18.99m | 545.40m | 1.50k | 28.78 | 3.84 | 22.08 | 1.95 | 18.61 | 18.61 | 274.44 | 139.40 | 1.04 | 3.35 | 3.22 | -- | 7.07 | 9.73 | 10.98 | 15.74 | 33.65 | 24.96 | 6.79 | 8.25 | 1.05 | 7.91 | 0.3056 | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
Shandong Boan Biotechnology Co Ltd | 78.65m | -15.19m | 548.90m | 813.00 | -- | 3.27 | -- | 6.98 | -0.2518 | -0.2518 | 1.30 | 2.78 | 0.2732 | 1.35 | 2.53 | 816,760.10 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
Ocumension Therapeutics | 31.35m | -48.32m | 549.62m | 444.00 | -- | 1.47 | -- | 17.53 | -0.6288 | -0.6288 | 0.4077 | 4.54 | 0.078 | 3.61 | 2.12 | 596,081.30 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
Arbutus Biopharma Corp | 12.01m | -68.80m | 551.56m | 73.00 | -- | 4.97 | -- | 45.92 | -0.4393 | -0.4393 | 0.0766 | 0.6362 | 0.0761 | -- | 5.41 | 177,890.40 | -43.56 | -52.62 | -50.25 | -58.11 | -- | -- | -572.81 | -537.81 | -- | -- | 0.00 | -- | -53.51 | 25.00 | -4.89 | -- | -2.40 | -- |
Boiron SA | 493.25m | 35.83m | 553.56m | 2.81k | 15.29 | 1.39 | 10.00 | 1.12 | 2.06 | 2.06 | 28.41 | 22.67 | 0.715 | 1.40 | 5.26 | 175,533.10 | 4.92 | 4.59 | 6.16 | 5.76 | 72.60 | 74.02 | 6.88 | 6.80 | 1.50 | -- | 0.0338 | 53.86 | -7.67 | -3.98 | -19.80 | -9.01 | -17.68 | -1.42 |
Shanghai Yizhong Pharmaceutical Co Ltd | 42.83m | 17.27m | 569.75m | 43.00 | 32.97 | 2.99 | -- | 13.30 | 0.66 | 0.66 | 1.64 | 7.28 | 0.2219 | 0.9416 | 3.28 | 7,826,913.00 | 8.95 | -0.9181 | 9.39 | -0.9485 | 93.54 | 93.19 | 40.32 | -6.11 | 12.66 | -- | 0.0342 | -- | 52.68 | -- | 13.09 | -- | 20.44 | -- |
Pulike Biological Engineering Inc | 150.48m | 17.35m | 570.28m | 1.68k | 32.82 | 1.64 | -- | 3.79 | 0.3946 | 0.3946 | 3.39 | 7.91 | 0.359 | 2.39 | 2.65 | 704,310.60 | 4.14 | 7.64 | 4.81 | 8.96 | 60.96 | 62.57 | 11.53 | 17.85 | 2.58 | 148.40 | 0.0146 | 52.48 | 1.84 | 15.55 | 3.99 | 5.17 | 41.58 | 18.47 |
Holder | Shares | % Held |
---|---|---|
Financi�re de l'�chiquier SAas of 28 Dec 2023 | 238.57k | 1.36% |
The Vanguard Group, Inc.as of 06 Jun 2024 | 136.71k | 0.78% |
Dimensional Fund Advisors LPas of 06 Jun 2024 | 83.74k | 0.48% |
SMA Gestion SAas of 30 Jun 2021 | 76.17k | 0.43% |
DNCA Finance SAas of 31 Mar 2023 | 74.85k | 0.43% |
HMG Finance SAas of 28 Mar 2024 | 70.95k | 0.40% |
Sycomore Asset Management SAas of 28 Mar 2024 | 69.77k | 0.40% |
HC Capital Advisors GmbHas of 31 Dec 2023 | 68.51k | 0.39% |
Norges Bank Investment Managementas of 31 Dec 2023 | 47.88k | 0.27% |
Gay-Lussac Gestion SAas of 31 Dec 2022 | 32.50k | 0.19% |